Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al., No. 2:25-cv-12383 [2]. - Investors who purchased stock during Lineage's IPO on July 25, 2024, are represented in the lawsuit, which asserts claims under Sections 11 and 15 of the Securities Act of 1933 [2][4]. Group 2: Company Background - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. - The company claimed in its IPO documents that it had "consistent cold chain demand" and strong cash flows, even during economic downturns, attributing potential growth to trends accelerated by the COVID-19 pandemic [4]. Group 3: Financial Performance - Following the IPO, Lineage's stock price has significantly declined from an initial price of $78 per share to around $40 per share, approximately half of its IPO value [5]. - In its fiscal Q4 2024 results announced on February 26, 2025, Lineage indicated that customers were reducing excess inventory, returning to a more normal seasonal pattern, which is expected to continue [5].

Core Viewpoint - A class action securities lawsuit has been filed against Lineage, Inc. alleging securities fraud related to its initial public offering (IPO) on July 26, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who purchased Lineage common stock in connection with the IPO [2]. - The complaint alleges that Lineage made false statements and concealed significant issues, including a decline in customer demand due to increased cold-storage supply and destocking of excessive inventory from the COVID-19 pandemic [3]. - It is claimed that Lineage's price increases prior to the IPO were unsustainable given the weakening demand environment [3]. - The company reportedly failed to counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or declining revenue, occupancy rates, and rent prices [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Lineage, Inc. during the relevant period have until September 30, 2025, to request appointment as lead plaintiff [4]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [5]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [5].

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ:LINE) investors of the September 30, 2025 to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Lineage securities between July 22, 2024 through August 1, 2025 (“the Class Period”). Follow the link below for more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened? On April 30, 2025, Lineage reported first quar ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company’s July 26, 2024 initial ...

Group 1 - The article discusses a securities fraud class action lawsuit against Lineage, Inc. initiated by investors who purchased or acquired the company's common stock related to its July 2024 IPO [3][4]. - The lawsuit alleges that Lineage and certain senior officers made misrepresentations regarding the company's business, historical financial results, and industry trends at the time of the IPO [4]. - Investors interested in participating as lead plaintiffs must file necessary documents by September 30, 2025, although participation in any recovery does not require serving as a lead plaintiff [5]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [6].

Group 1 - The Gross Law Firm has issued a notice to shareholders of Lineage, Inc. regarding potential legal matters [1]

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit. Investors have until September 30, 2025, to ask the Court to ...

Core Viewpoint - Lineage Cell Therapeutics has initiated a new islet cell transplant program targeting Type 1 Diabetes, focusing on large-scale production of islet cells [1] Group 1: Company Developments - The company is a clinical-stage biotechnology firm specializing in allogeneic cell therapies for serious medical conditions [1] - The new program aims to leverage the company's manufacturing capabilities to address the production challenges of islet cells [1] Group 2: Industry Context - The initiative is part of a broader effort to develop innovative treatments for Type 1 Diabetes, a condition that currently lacks effective long-term solutions [1]

Scotiabank analyst Greg McGinniss sets a new price target of $43 for NASDAQ:LINE, indicating a potential upside of 5.94%.The stock's volatility is highlighted by its year-long fluctuation between $84.86 and $38.83.Rosen Law Firm encourages investors to seek legal counsel ahead of a lead plaintiff deadline, potentially affecting investor sentiment and stock performance.Lineage, Inc. (NASDAQ: LINE) is a company that has recently caught the attention of investors and analysts alike. On September 5, 2025, Greg ...

Core Viewpoint - Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline for a class action lawsuit related to the company's July 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 30, 2025 [3]. - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5]. Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage experienced a sustained weakening in customer demand due to increased cold-storage supply and destocking of excessive inventory by customers [5]. - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5]. - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Rosen Law Firm has been recognized for its leadership in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].